PEGS Boston Summit 2026

April 27, 2026

Primrose Bio attended the 22nd Annual PEGS Boston Summit in Boston, showcasing how the Pfenex Expression Technology® platform supports complex protein production, site-specific conjugation, streamlined protein recovery, and VHH-ADC development.

Where we presented:

Luncheon Presentation
Diane Retallack, PhD, President & COO
“Streamlining Discovery and Development Workflows Using Engineered P. fluorescens Strains for ncAA Incorporation and Extracellular Protein Production”
Monday, May 11 | 12:10 PM

Scientific Poster A083
Russell Coleman, Director, Strain Engineering
“Preclinical Development of a VHH-ADC Using the Pfenex Platform”
Monday, May 11, 5:55 PM – Tuesday, May 12, 2:20 PM

Booth #624, Ensemble Ballroom
Louis J. Cantolupo, Alec Tzianabos, and the Primrose Bio team were on hand to connect.

Presented at PEGS Boston 2026 by Primrose Bio. Streamlined product discovery and development workflows are critical to facilitate efficient decision making and candidate advancement. Improvements in extracellular (EC) localization and ncAA incorporation within the Pfenex platform can accelerate discovery and development timelines. Engineered host strains show EC production of a wide range of proteins, enabling streamlined recovery and analysis. Further, high fidelity, high titer production of target proteins with 100% ncAA incorporation has been established, with titers up to 15g/L in fermentation.

#

Return to Resources